HOME › DRUGS › SOTROVIMAB
ACTIVE SUBSTANCE / INN

SOTROVIMAB

Brand name(s): Xevudy
EMA LISTED
WITHDRAWN
COVID-19 virus infection
ACTIVE SUBSTANCE
Sotrovimab
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
XevudyGlaxoSmithKline Trading Services LimitedWithdrawn18/02/2026COVID-19 virus infection

FULL INTELLIGENCE ON SOTROVIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →